Day: January 17, 2024

Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation (“Reverse Stock Split”)

ANN ARBOR, MI / ACCESSWIRE / January 17, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...

Fortified Health Security: 2024 Horizon Report Reveals Startling Cybersecurity Trends, Industry Outlook for Healthcare Organizations

Latest edition of the free, biannual report covers emerging cybersecurity threats, critical legislative developments, and emerging AI best practices for...

Billionaire, Global Philanthropist and Healthcare Pioneer Dr. Kiran Patel Enters the PharmTech Industry to Empower the Community Pharmacy

Move represents expansion of parent company KARE Rx Partners' mission to serve the pharmacy industry, connecting independent pharmacy owners with...

CPSI and PointClickCare Announce Exclusive Referral Partnership for TruBridge RCM Services to Skilled Nursing Facilities

MOBILE, Ala.--(BUSINESS WIRE)--CPSI (NASDAQ: CPSI), a healthcare solutions company, today announced that the Company and PointClickCare, a leading healthcare technology...

The Government Draws Attention to Swedish Alzheimer’s Research and Together with the Swedish Alzheimer’s Foundation Visit AlzeCure Pharma

STOCKHOLM, SWEDEN / ACCESSWIRE / January 17, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical...

Fathom Announces Partnership with Google Cloud, Adding its Autonomous Medical Coding Solution to Google Cloud Marketplace

This collaboration will boost access and integration with best-in-class autonomous medical coding for healthcare providers.SAN FRANCISCO--(BUSINESS WIRE)--#AutonomousMedicalCoding--Fathom, the leader in...

FDA Clearance Granted for First AI-Powered Medical Device to Detect All Three Common Skin Cancers (Melanoma, Basal Cell Carcinoma and Squamous Cell Carcinoma)

DermaSensor Now Available to Improve Skin Cancer Detection in Primary CareMIAMI--(BUSINESS WIRE)--DermaSensor Inc. announces FDA clearance for its real-time, non-invasive...

CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

HOUSTON, TX / ACCESSWIRE / January 17, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company...

error: Content is protected !!